ArticleLeukemia2014
Prognostic gene mutations and distinct gene- and microRNA-expression signatures in acute myeloid leukemia with a sole trisomy 8.
Abstract readLetter
In one paragraph
Article in Leukemia, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Trial
- Outcomes and prognostic impact of trisomy 8 in acute myeloid leukemia patients treated with intensive chemotherapy.Blood cancer journal · 2025Article
- Article
- Flexible model-based clustering of mixed binary and continuous data: application to genetic regulation and cancer.Nucleic acids research · 2017Article
- Karyotyping and analysis of GNAS locus in intramuscular myxomas.Oncotarget · 2017Article
- Article
- Acute Myelogenous Leukemia With Trisomy 8 and Concomitant Acquired Factor VII Deficiency.Journal of investigative medicine high impact case reportsArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
24 authors.
Heiko BeckerThe Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
Kati MaharryThe Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
Krzysztof MrózekThe Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
Stefano VoliniaThe Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
Ann-Kathrin EisfeldThe Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
Michael D RadmacherThe Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
Jessica KohlschmidtThe Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
Klaus H MetzelerThe Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
Sebastian SchwindThe Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
Susan P WhitmanThe Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
Jason H MendlerThe Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
Yue-Zhong WuThe Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
Deedra NicoletThe Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
Peter PaschkaThe Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
Bayard L PowellComprehensive Cancer Center, Wake Forest University, Winston-Salem, NC, USA.
Thomas H CarterDepartment of Internal Medicine, University of Iowa, Iowa City, IA, USA.
Meir WetzlerDepartment of Medicine, Roswell Park Cancer Institute, Buffalo, NY, USA.
Jonathan E KolitzMonter Cancer Center, Hofstra North Shore-Long Island Jewish School of Medicine, Lake Success, NY, USA.
Andrew J CarrollDepartment of Genetics, University of Alabama at Birmingham, Birmingham, AL, USA.
Maria R BaerDepartment of Medicine and Greenebaum Cancer Center, University of Maryland, Baltimore, MD, USA.
Michael A CaligiuriThe Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
Richard M StoneDepartment of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
Guido Marcucci *The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
Clara D Bloomfield *The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
Funding
Member Site CoreU10CA180821 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI Evanthia Galanis · 2014 to 2026
$177.3MCANCER AND LEUKEMIA GROUP B MINORITY SATELLITE SUPPLEMENU10CA031946 · NCI · UNIVERSITY OF CHICAGO · PI BERTAGNOLLI, MONICA M · 1985 to 2013
$158.4MTranslational Therapeutics Research Program (TT)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI Tasleem J Padamsee · 1985 to 2026
$132.3MCANCER &LEUKEMIA GROUP B STATISTICAL CENTERU10CA033601 · NCI · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI SARGENT, DANIEL J. · 1985 to 2013
$69.4MSPORE Leukemia Tissue BankP50CA140158 · NCI · OHIO STATE UNIVERSITY · PI BLOOMFIELD, CLARA D · 2009 to 2013
$11.2MCancer and Leukemia Group B Human Specimen RepositoriesU24CA114725 · NCI · UNIVERSITY OF CHICAGO · PI BERTAGNOLLI, MONICA M · 2005 to 2014
$11.1MCancer and Leukemia Group B - Leukemia Correlative SciencesU10CA101140 · NCI · OHIO STATE UNIVERSITY · PI MARCUCCI, GUIDO · 2003 to 2013
$10.3MCancer and Leukemia Group B - The Ohio State UniversityU10CA077658 · NCI · OHIO STATE UNIVERSITY · PI BLOOMFIELD, CLARA D · 1998 to 2013
$6.0MITSC for Leukemia: Novel Molecular Strategies for NCTN: "Individualized" TherapieU10CA180861 · NCI · OHIO STATE UNIVERSITY · PI BLOOMFIELD, CLARA D, MARCUCCI, GUIDO · 2014 to 2018
$3.4MMolecular characterization of normal cytogenetics AML in older patientsR21CA129657 · NCI · OHIO STATE UNIVERSITY · PI MARCUCCI, GUIDO · 2008 to 2009
$371kNCI NIH HHS CA101140NCI NIH HHS CA114725NCI NIH HHS CA129657NCI NIH HHS CA140158NCI NIH HHS CA16058NCI NIH HHS CA31946NCI NIH HHS CA33601NCI NIH HHS CA77658NCI NIH HHS P30 CA016058NCI NIH HHS P50 CA140158NCI NIH HHS R21 CA129657NCI NIH HHS U10 CA031946NCI NIH HHS U10 CA033601NCI NIH HHS U10 CA077658NCI NIH HHS U10 CA101140NCI NIH HHS U10 CA180821NCI NIH HHS U10 CA180861NCI NIH HHS U24 CA114725
Abstract
PubMed holds no abstract for this paper.
Indexed as
Chromosomes, Human, Pair 8MutationTrisomyAdolescentAdultAgedAged, 80 and overDioxygenasesDisease-Free SurvivalDNA-Binding ProteinsFemalefms-Like Tyrosine Kinase 3HumansLeukemia, Myeloid, AcuteMaleMicroRNAsDioxygenasesDNA-Binding ProteinsFLT3 protein, humanfms-Like Tyrosine Kinase 3MicroRNAsProto-Oncogene ProteinsTET2 protein, human
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.